All Type of News
Geoyoung to sever relationship with ZPK
Geoyoung, the largest local pharmaceutical wholesaler, is moving to sever its relationship with Zuellig Pharma Korea (ZPK), following Dongwon Pharm.
Sources said that if Geoyoung is withdrawn, this will deal a seri...
Herceptin approved for treatment of HER2-positive advanced stomach cancer
The Korea Food and Drug Administration has approved Herceptin (trastuzumab) in combination with chemotherapy for use in patients with HER2-positive metastatic stomach (gastric) cancer, Roche Korea said on March 30.
...
KFDA to evaluate safety and efficacy of 202 off-label drugs by 2015
The Korea Food and Drug Administration has unveiled its plan to evaluate the safety and efficacy of 202 off-label drugs by 2015 through review of clinical data to see if the results support the drug for a specific use...
Radio tag for drugs to be planned
The government announced on March 31 that radio tags will be placed on the containers of 50 percent of all drugs sold here by 2015, as part of efforts to create a wireless tracking system that enables better inventory...
1,444 essential drugs designated
The Health Insurance Review Assessment and Service announced on March 31 a list of 1,444 medicines in six therapeutic categories that should be supplied without discontinuation.
The HIRAS’s announcement came at a t...
KPMA, CPIA to cooperate
The Korea Pharmaceutical Manufacturers Association (KPMA) said on March 31 that it has signed Wednesday a memorandum of understanding (MOU) with the China Pharmaceutical Industry Association (CPIA) to step up exchange...
New drug pricing plan to hit hospital wholesalers
Hospital-oriented wholesalers will face a bumpy road ahead as many hospitals are likely to seek officially-approved profits under the government’s new drug-pricing system, which will pay medical institutions and drug ...
KFDA to introduce Phase zero(0) clinical trial guideline
The Korea Food and Drug Administration unveiled its plan to formulate a guideline for Phase zero(0) clinical trial as part of efforts to facilitate rational drug selection, identify therapeutic failures early, and com...
KFDA approves arthritis treatment Orencia
The Korea Food and Drug Administration said on Mach 29 it has granted final approval to Bristol-Myers Squibb's (BMS) Orencia — a potential blockbuster arthritis treatment, according to BMS Korea.
Administered intra...
Handok strengthens tie-ups with Nycomed
Handok Pharm says its has signed an licensing agreement with Nycomed International Management GmbH, a global pharmaceutical company headquartered in Zurich, Switzerland for the exclusive distribution rights in Korea o...
